Company profile: Suvoda
1.1 - Company Overview
Company description
- Provider of clinical trial management software and services, including Suvoda IRT to manage drug distribution and patient dosing, eConsent to enable electronic trial participation consent, and eCOA to collect patient outcome data, backed by client services and integration services to streamline trial processes.
Products and services
- Suvoda eCOA: An electronic Clinical Outcome Assessments product that simplifies collection of data on patient outcomes in clinical trials by enabling streamlined, electronic capture and review of outcome assessments
- Suvoda eConsent: An electronic platform facilitating the consent process by enabling clinical trial participants to electronically receive study information and submit consent to trial participation
- Suvoda IRT: A software-based tool for trial sponsors and site professionals to manage drug distribution and patient dosing in clinical trials.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Suvoda
Molecular Health
HQ: Germany
Website
- Description: Provider of cloud-based software for evidence-based healthcare decision support and drug development, including MH Guide for genome-based therapy planning for healthcare providers and clinical laboratories, and Dataome, a technology platform that analyzes molecular and clinical patient data against global medical, biological, and pharmacological knowledge to deliver insights for pharmaceutical and biotech professionals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Health company profile →
Wisecube
HQ: United States
Website
- Description: Provider of a hybrid cloud graphical AI platform focused on life science research acceleration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wisecube company profile →
Aparito
HQ: United Kingdom
Website
- Description: Provider of an eCOA platform (Atom5) that digitises clinical trials and captures real-world patient data via video assessments, ePROs, wearables, telemedicine, and eConsent, delivering real-time insights to clinical teams. Part 11, GDPR and HIPPA compliant, supporting patient-centric trials at scale in 193 countries and 125 languages.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aparito company profile →
nPruv
HQ: United States
Website
- Description: Provider of health IT solutions that allow patients, physicians, and sponsors to find, match, and share clinical trial opportunities, decreasing the time and cost of patient recruitment for sponsors while improving revenue and reducing workflow for physicians and clinics hosting the trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full nPruv company profile →
MedSciNet
HQ: Sweden
Website
- Description: Provider of tailor-made database applications for clinical trials, built and managed by an internet company, supporting well-organised, high-quality medical data to create preconditions for clinical researchers and other professionals to achieve medical breakthroughs and innovations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedSciNet company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Suvoda
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Suvoda
2.2 - Growth funds investing in similar companies to Suvoda
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Suvoda
4.2 - Public trading comparable groups for Suvoda
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →